Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) Short Interest Down 55.7% in January

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) was the target of a large decrease in short interest in January. As of January 31st, there was short interest totalling 6,600 shares, a decrease of 55.7% from the January 15th total of 14,900 shares. Based on an average daily volume of 39,500 shares, the days-to-cover ratio is currently 0.2 days.

Reviva Pharmaceuticals Price Performance

RVPHW stock traded down $0.00 during trading on Thursday, reaching $0.15. The company had a trading volume of 7,251 shares, compared to its average volume of 31,026. Reviva Pharmaceuticals has a 52 week low of $0.07 and a 52 week high of $1.11. The business has a 50 day moving average of $0.21 and a 200 day moving average of $0.16.

About Reviva Pharmaceuticals

Reviva Pharmaceuticals Holdings, Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis.